STAT3 and metabolic dysfunction-associated steatotic liver disease: Considering that CCR5 deficiency affects hepatic STAT3 signaling and lipid metabolism (Figure 1 and Figure 3), it is essential to study the role of CCR5 in hepatocytes under NAFLD.